Our data showed decreased levels of CDK5 tv1 and 2 in T2D patients compared to controls; though they exhibited different distribution patterns and correlated with different clinicopathological parameters in the CTRF−versus CTRF+ groups, but both with increased serum insulin levels. Here, CDK5 is linked to type 2 diabetes mellitus.